Bridgewater Associates’s CryoPort CYRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CYRX
BCM
FAM
Bridgewater Associates's CYRX Position: Q4 2022 in Review
Bridgewater Associates sold out of CryoPort (CYRX) in Q4 2022, closing a stake of 75,277 shares — an estimated $1.83M sold.
Bridgewater Associates first reported a position in CYRX in Q2 2021 and held it in 6 quarters. The position peaked at $2.95M in Q2 2021. 171 funds tracked by Wall St. Rank hold CYRX as of Q4 2022.
- Bridgewater Associates reported no remaining CryoPort position as of Q4 2022 after selling out during the quarter.
- Bridgewater Associates sold 75,277 CryoPort shares in Q4 2022, an estimated $1.83M.
- Bridgewater Associates first reported a position in CryoPort in Q2 2021 and held it in 6 quarters.
- Bridgewater Associates's CryoPort position peaked at $2.95M in Q2 2021.
- 171 funds tracked by Wall St. Rank held CryoPort as of Q4 2022.
Based on Bridgewater Associates's 13F filing for Q4 2022, filed 13 Feb 2023.